GlassScriptPhysician profile
Arun Rajaram
NPI 1881838993
$2,756.24
in general payments reported to CMS, 2019-2025
18 companies · $65.92 in 2025
The $65.92 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,188 · 2020: $215 · 2021: $678 · 2022: $166 · 2023: $221 · 2024: $224 · 2025: $65.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $679.19 | 2019-2022 | |
| Abbott Laboratories | $558.51 | 2019-2021 | |
| Nalu Medical, INC. | $206.73 | 2021-2023 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $187.05 | 2019-2020 | |
| Smith+Nephew, INC. | $163.24 | 2019 | |
| Boston Scientific Corporation | $137.59 | 2019-2021 | |
| Djo, LLC | $133.98 | 2024 | Cmf |
| Royal Biologics, INC. | $125.00 | 2019 | |
| Amarin Pharma, INC. | $125.00 | 2019 | |
| Si-Bone, INC. | $103.43 | 2021 | |
| Bioventus LLC | $92.49 | 2024-2025 | Durolane, Gelsyn-3 |
| Medtronic, INC. | $70.59 | 2021 | |
| Biotronik Nro, INC. | $63.06 | 2024 | Prospera |
| Stimwave Technologies Incorporated | $38.84 | 2020 | |
| Fidia Pharma USA INC. | $24.34 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $19.18 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.13 | 2023 | Exparel, Zilretta |
| Sanofi-Aventis U.S. LLC | $13.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Rajaram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.